Navigation Links
MicroActive Corporation Acquired by Linden and Edgewater
Date:11/6/2007

RENO, Nev., Nov. 6 /PRNewswire/ -- MicroActive Corporation, a subsidiary of Barrier Safe Solutions International, announced today that BSSI has been acquired by Linden LLC and The Edgewater Funds.

In addition to MicroActive, BSSI also owns Microflex Corporation and FoodHandler, Inc. BSSI, headquartered in Reno, NV, is a leading supplier of health and safety barrier products to the foodservice, emergency medical, dental, laboratory, automotive and industrial markets throughout North America. With a focus on premium quality and outstanding service, BSSI annually sells more than six billion disposable gloves under the Microflex and FoodHandler brands.

Mike Mattos, Chief Executive Officer of BSSI said, "We look forward to working together with our new partners at Linden and Edgewater to further grow our business and expand our infection control, food service and industrial safety platforms through continued organic growth as well as additional acquisitions."

MicroActive is committed to developing and marketing innovative anti- microbial technologies, products and solutions for healthcare, food, agricultural, medical, consumer and industrial products. Derek Warneke, General Manager of MicroActive commented, "We are very excited about the breakthrough levels of performance demonstrated by our patented antimicrobial systems and the unique opportunity we have to effectively address infection control and food safety issues. Our highly-engineered systems deliver market leading levels of performance with unmatched safety in a cost effective platform".

About BarrierSafe Solutions International BarrierSafe is a leading developer and marketer of branded disposable hand protection and related products. The company offers an extensive selection of high quality disposable gloves and other specialized products for a diverse range of growing niche markets, including the foodservice, dental, laboratory, emergency medical services, nonacute healthcare, automotive and general industrial segments, in which branding, quality, innovation and features are key differentiators that drive end-user demand and loyalty.

About Linden, LLC

Linden is a Chicago-based private equity firm focused exclusively on the healthcare and life science industries. Linden's strategy is based upon three key elements: i) healthcare and life science industry specialization, ii) integration of transaction and operating expertise, and iii) focus on building strategic relationships, particularly with global healthcare and life science companies.

About The Edgewater Funds

The Edgewater Funds is a leading private equity firm based in Chicago, Illinois. Through 15 years of experience and $1 billion in capital under management, Edgewater has distinguished itself through successful partnerships with quality middle market companies. Edgewater is currently investing Edgewater Growth Capital Partners II, L.P. a $470 million equity fund. Edgewater is distinguished by the depth of experience of its Partners who have been successful private equity investors, CEO's and business leaders.


'/>"/>
SOURCE MicroActive Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 2017 , ... "ProDOF is the perfect set of tools for video editors that want to ... said Christina Austin - CEO of Pixel Film Studios. , Video editors using ProDOF ... of a DSLR racking focus from one area into the next. ProDOF comes with ...
(Date:1/21/2017)... Rosa, CA (PRWEB) , ... January 21, 2017 ... ... announce that Redwood Family Dermatology has recently joined their multi-specialty medical ... a full range of cosmetic services. , “We’re excited to add this excellent ...
(Date:1/20/2017)... ... ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. Built for durability, this ... wheels, it can be wheeled out of the way and stored when not in use. ... have transformed the feedback from customers into specific enhancements and created a new product that ...
(Date:1/20/2017)... ... , ... Doctor C LLC, a company based out of Arizona that focuses ... the marketing and distribution of its product, The Right C. , The Right C ... than traditional vitamin C supplements. At the trade show, Doctor C had the opportunity ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... -- Entscheidung fällt als Reaktion ... Die internationale humanitäre Stadt soll um knapp 2800 m² erweitert ... Seine Hoheit Scheich Muhammad bin Raschid Al ... Dubai , hat den Auftrag erteilt, ... City IHC) zu verdreifachen, um den Betrieb zur Unterstützung ...
(Date:1/19/2017)... 19, 2017 The global immunomodulators market ... 2025, according to a new study by Grand ... be predominantly driven by high R&D investments employed ... production of new and therapeutically advanced drugs. This ... at an unprecedented rate into the immunomodulators market ...
(Date:1/19/2017)... 19, 2017 The U.S. Food and Drug Administration ... Constipation (CIC) in adult patients. "No one ... said Julie Beitz , M.D., director of the Office ... Evaluation and Research. "With the availability of new therapies, patients ... their condition." ...
Breaking Medicine Technology: